Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Adjuvant treatment for elderly patients with colon cancer. An observational study.

Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P, Bajetta E, Platania M, Alabiso O, Miraglia S, Bertona E, Oniga F, Biason R, Chetrì MC, Fedele P, Massara G, Romaniello I, Negru ME, Luchena G, Giordano M, Buzzi F, Ricottao R, Sienao S, Monfardini S.

Anticancer Res. 2008 Jul-Aug;28(4C):2513-8.

2.

Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.

Fata F, Mirza A, Craig G, Nair S, Law A, Gallagher J, Ellison N, Bernath A.

Cancer. 2002 Apr 1;94(7):1931-8. Review.

3.

Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Schrag D, Cramer LD, Bach PB, Begg CB.

J Natl Cancer Inst. 2001 Jun 6;93(11):850-7.

PMID:
11390534
4.

A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.

Phelip JM, Molinié F, Delafosse P, Launoy G, Trétarre B, Bara S, Buémi A, Velten M, Danzon A, Ganry O, Bouvier AM, Grosclaude P, Faivre J.

Gastroenterol Clin Biol. 2010 Feb;34(2):144-9. doi: 10.1016/j.gcb.2009.08.012. Epub 2010 Jan 15.

5.

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD.

J Am Geriatr Soc. 2009 Aug;57(8):1403-10. doi: 10.1111/j.1532-5415.2009.02355.x. Epub 2009 Jun 25.

PMID:
19563521
6.

Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.

Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM; Norwegian Gastrointestinal Cancer Group.

Acta Oncol. 2009;48(3):368-76. doi: 10.1080/02841860902755244.

PMID:
19242829
7.

Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.

Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG.

Can J Surg. 2009 Apr;52(2):92-7.

8.

Young age influences treatment but not outcome of colon cancer.

Quah HM, Joseph R, Schrag D, Shia J, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Ann Surg Oncol. 2007 Oct;14(10):2759-65. Epub 2007 Jun 26.

PMID:
17593332
9.

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG, Sargent DJ.

J Clin Oncol. 2008 May 10;26(14):2336-41. doi: 10.1200/JCO.2007.15.8261.

PMID:
18467725
10.

Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.

Mahoney T, Kuo YH, Topilow A, Davis JM.

Arch Surg. 2000 Feb;135(2):182-5.

PMID:
10668878
11.

Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR.

Dis Colon Rectum. 2008 May;51(5):503-7. doi: 10.1007/s10350-008-9246-z. Epub 2008 Mar 6.

PMID:
18322753
12.

Patient age and cancer treatment decisions. Patient and physician views.

Kutner JS, Vu KO, Prindiville SA, Byers TE.

Cancer Pract. 2000 May-Jun;8(3):114-9.

PMID:
11898135
13.

[Adjuvant chemotherapy for colon cancer].

Dahl O.

Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3094-6. Review. Norwegian.

14.

Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.

Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC.

J Am Coll Surg. 2009 Feb;208(2):202-9. doi: 10.1016/j.jamcollsurg.2008.10.016. Epub 2008 Dec 18.

PMID:
19228531
15.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A.

J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.

PMID:
19451431
16.

Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.

Winget M, Hossain S, Yasui Y, Scarfe A.

Cancer. 2010 Oct 15;116(20):4849-56. doi: 10.1002/cncr.25250.

17.

The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region.

van Leeuwen BL, Påhlman L, Gunnarsson U, Sjövall A, Martling A.

Crit Rev Oncol Hematol. 2008 Sep;67(3):229-36. doi: 10.1016/j.critrevonc.2008.03.005. Epub 2008 Apr 28.

PMID:
18440820
18.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.

Cancer. 2006 Dec 1;107(11):2581-8.

19.

Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.

Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, Grann VR, Hershman DL.

J Clin Oncol. 2006 May 20;24(15):2368-75. Epub 2006 Apr 17.

PMID:
16618946
20.

Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.

Gertler R, Rosenberg R, Schuster T, Friess H.

Eur J Cancer. 2009 Nov;45(17):2992-9. doi: 10.1016/j.ejca.2009.07.008. Epub 2009 Aug 12.

PMID:
19682890

Supplemental Content

Support Center